U.S. Markets open in 3 hrs 38 mins

Celldex Therapeutics, Inc. (CLDX)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.09+0.03 (+0.98%)
At close: 4:00PM EDT
People also watch
ACADARRYCLVSSRPTEXEL
Currency in USD

Valuation Measures

Market Cap (intraday) 5386.57M
Enterprise Value 3N/A
Trailing P/E -2.59
Forward P/E 1-3.00
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)55.09
Price/Book (mrq)1.55
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-1,773.41%
Management Effectiveness
Return on Assets (ttm)-23.50%
Return on Equity (ttm)-50.45%
Income Statement
Revenue (ttm)7.02M
Revenue Per Share (ttm)0.06
Quarterly Revenue Growth (yoy)17.70%
Gross Profit (ttm)6.79M
EBITDA -119.75M
Net Income Avi to Common (ttm)-128.12M
Diluted EPS (ttm)-1.19
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)167.02M
Total Cash Per Share (mrq)1.34
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.42
Book Value Per Share (mrq)2.00
Cash Flow Statement
Operating Cash Flow (ttm)-113.4M
Levered Free Cash Flow (ttm)-58.54M

Trading Information

Stock Price History
Beta 3.00
52-Week Change 3-27.49%
S&P500 52-Week Change 314.52%
52 Week High 35.13
52 Week Low 32.85
50-Day Moving Average 33.22
200-Day Moving Average 33.54
Share Statistics
Avg Vol (3 month) 31.81M
Avg Vol (10 day) 31.24M
Shares Outstanding 5125.11M
Float 117.67M
% Held by Insiders 10.54%
% Held by Institutions 189.20%
Shares Short 319.82M
Short Ratio 39.93
Short % of Float 323.75%
Shares Short (prior month) 319.19M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3Mar 10, 2008